omega-n-methylarginine has been researched along with ondansetron in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (ondansetron) | Trials (ondansetron) | Recent Studies (post-2010) (ondansetron) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 3,380 | 1,216 | 994 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blauw, GJ; Bruning, TA; Chang, PC; van Zwieten, PA; Vermeij, P | 1 |
1 other study(ies) available for omega-n-methylarginine and ondansetron
| Article | Year |
|---|---|
Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Forearm; Free Radical Scavengers; Granisetron; Guanylate Cyclase; Humans; Indazoles; Male; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Ondansetron; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Vasodilation | 1993 |